As an assistant professor in the Department of Medical Oncology and within the Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, my focus is on acute and chronic leukemias, myelodysplastic syndromes, myeloproliferative neoplasms and bone marrow failure states. My research focuses on initiating both early and late phase clinical trials to advance our knowledge and treatments for these conditions. My goal is to bring novel treatments to our patients by helping our colleagues in the lab bring their new compounds to the clinic. I also have an interest in quality-of-life research and have started projects looking at ways to improve symptoms such as fatigue and weakness in our patients. Lastly, I am the principal investigator on our biorepository project looking at blood and marrow samples from patients and assessing them in the lab for sensitivity to various therapeutics. To increase my research acumen, I have completed a certificate in clinical investigational theory here at Jefferson and plan on continuing to learn and grow my independent research career.
Chetan S. Jeurkar, DO
Assistant Professor
Contact Information

Honickman Center
1101 Chestnut Street
14th Floor
Philadelphia, PA 19107
Assistant Professor
Research & Clinical Interests
Education
Medical School
Rowan School of Osteopathic Medicine, Stratford, NJ - 2015
Internship
Drexel University College of Medicine/Hahnemann University Hospital, Philadelphia, PA - 2016
Residency
Drexel University College of Medicine/Hahnemann University Hospital, Philadelphia, PA - 2018
Fellowship
Hematology/Medical Oncology, Thomas Jefferson University Hospitals, Philadelphia, PA - 2024
Publications
- A Century of Hypomethylating Agent: A Remarkable Response to Azacitidine Monotherapy for Relapsed Acute Myeloid Leukemia – A Case Report
- A prospective study of posttransplant cyclophosphamide for unrelated donor peripheral blood stem cell transplant with special attention to graft content and the impact of a higher γδ T cell dose
- Copper Deficiency Mimicking Myelodysplastic Syndrome: Zinc Supplementation in the Setting of COVID-19
- Immunophenotypic Differences in Cerebrospinal Fluid and Peripheral Blood Demonstrating Cancer Heterogenicity in Acute Myeloid Leukemia Patient
- Inpatient versus outpatient hypomethylating agent induction for acute myeloid leukemia as a predictor for survival